Brent R. Bellows is a partner with Knowles Intellectual Property Strategies (KIPS) in Atlanta, Georgia.  Dr. Bellows focuses on pharmaceutical and biotechnology patent strategy, including domestic and international patent preparation and prosecution, portfolio creation and management, and due diligence.  As part of his practice, Dr. Bellows is particularly attuned to the strategic positioning and strengthening of patent portfolios encompassing clinically valuable assets in light of potential competitor challenges.  Dr. Bellows represents a diverse range of clients, from entry-level and emerging start-ups to global corporations.

​

Dr. Bellows is active in the IP community, serving as past Chair of the IP Section of the Georgia State Bar, an organization of over twelve hundred IP lawyers.  In this capacity, Dr. Bellows led the organization of educational programming, was the official representative for the State Bar, and regularly communicated with IP Bars and organizations throughout the country.  Dr. Bellows is also a lecturer on IP issues domestically and internationally.

​

Dr. Bellows has been named a “Rising Star” by Super Lawyers and one of Georgia’s “Legal Elite” by Georgia Trend Magazine in the area of Intellectual Property Law.  Dr. Bellows has also been named to Intellectual Asset Management Magazine’s “Intellectual Property Strategy 300” from 2015-2019.  

​

Dr. Bellows received a Ph.D. from the University of Alabama at Birmingham in human genetics, where his thesis focused on the identification of tumor antigens and his research covered several disciplines, including molecular biology, molecular genetics, biochemistry, immunology, and virology.  

​

Following graduate school, Dr. Bellows attended the University of Virginia Law School. Thereafter he joined King & Spalding’s IP group in Atlanta.  After practicing for several years, Dr. Bellows serves as a law clerk to Judge Charles A. Pannell, Jr. in the Federal District Court for the Northern District of Georgia, where he assisted with all intellectual property cases on Judge Pannell’s docket.  In 2010, he joined KIPS as a partner. 

​

Dr. Bellows’ recent scholarly lectures and writings include:

​

• “Convergence of Medical Devices/Diagnostics/Data Gathering,” Diagnostics/Medtech Panel Breakfast, Moderator, SEBIO Investor and Partnering Forum, Miami, Florida, November 7, 2019.

 

• Regenerative Medicine Panel, Moderator, SEBIO Investor and Partnering Forum, Pinehurst, North Carolina, November 14-16, 2017.

• “Program Host, 5th Annual IP Spring Gala, State Bar of Georgia, Atlanta, Georgia, February 24, 2017.

• “Continuation Applications Can Hurt Patent Portfolios,” Author, Daily Reporter Magazine -Special In-House Section, January 9, 2017.

• “Incubators – Transformative Effects on the Life Science Industry,” Moderator, SEBIO Investor and Partnering Forum, Jacksonville, Florida, December 14, 2016.

• 22nd Annual Intellectual Property Institute, Program Chair, Amelia Island, Florida, September 15-17, 2016.

• “Brexit, What Does It Mean for Intellectual Property Protection in Europe?” IP Institute, Amelia Island, Florida, September 17, 2016.

• 21st Annual Intellectual Property Institute, Program Vice-Chair, Amelia Island, Florida, September 17-19, 2015.

•  “Patent Reform Legislation: What Is It? How Did We Get Here? Where Should We Be Going?” Panelist, IP Institute, Amelia Island, Florida, September 18, 2015.

•  “§101 Post-Myriad Guidelines: Product of Nature,” Speaker, Georgia Tech School of Business, Atlanta, Georgia, March 9, 2015.

•  “Are You Smarter Than a Federal Circuit Judge,” Moderator, 3rd Annual IP Spring Gala, State Bar of Georgia, February 23, 2015.

• “Section 101: One Year Later,” Moderator, IP Institute, Amelia Island, Florida, September 15, 2014.

•  “Has the Dust Settled? Patent Prosecution Post-AIA,” Moderator, 25th Annual North American Entertainment, Sports and Intellectual Property Law Conference, Montego Bay, Jamaica, November 6-10, 2013.

• “First-Inventor-To-File Under the AIA: Rules, Implications, and Strategies Every IP Attorney Should Know,” Panelist, IP Section of the Georgia State Bar, Atlanta, Georgia, February 27, 2013.

• “Copyrighting DNA: Protecting Synthetic DNA Sequences as a Work of Authorship,” Panelist, Georgia State University College of Law, Atlanta, Georgia, January 31, 2013.

• “Monetisation Models in Biotech and Pharma,” Co-Author, Intellectual Asset Management Magazine, Issue 57, January/February 2013.

• 24th Annual North American Entertainment, Sports and Intellectual Property Law Conference, Speaker, Institute of Continuing Legal Education in Georgia, Cancun, Mexico, November 7-11, 2012.

• “Intellectual Property Laws: The Apple v. Samsung Case,” Author, E-Commerce Law & Policy, October 2012.

• U.S. Patent Reform Forum 2012: “The AIA and First-to-File,” Speaker, Managing Intellectual Property Forum, Washington D.C., March 27, 2012.

• “Robin Hood, the Magna Carta and the European Convention on Human Rights,” Co-Author, Intellectual Asset Management Magazine, Issue 52, March/April 2012.

•  “Implications of the America Invents Act of 2011: What Every Intellectual Property Manager Should Know,” Speaker, India Institute of Management, Bangalore, India, 2012.

• “Avoiding the Joint Infringement Trap in the United States Through Proper Claim Drafting,” Speaker, Global IP Convention, New Delhi, India, 2012.

• “Protecting the value of software patents in the United States,” Author, E-Commerce Law & Policy, 2011.